Newsroom

Fisher & Paykel Healthcare has announced the launch of F&P Nova Micro™ nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in the USA.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Thursday, 28 November 2024 its financial results for the six months ended 30 September 2024.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided the attached Chair’s speech and CEO’s slide presentation for the 2024 Annual Shareholders’ Meeting.

Read more

Fisher & Paykel Healthcare Corporation Limited announced that it has provided guidance for the first half of the 2025 financial year, which ends 30 September 2024.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today it has appointed Mark Cross to the Board as a non-executive director with effect from 1 October 2024.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced the launch of the F&P my820 System into the United States.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) has provided a copy of the Notice of Meeting for its 2024 Annual Shareholders’ Meeting

Read more

Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan operating in respect of the dividend payable on Wednesday 10 July 2024 has been set

Read more

Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) announced today that it intends to release on Wednesday, 29 May 2024 its financial results for the year ended 31 March 2024.

Read more

Fisher & Paykel Healthcare launches revolutionary F&P Solo™ Nasal mask for obstructive sleep apnea in the United States

Read more

– Fisher & Paykel Healthcare Corporation Limited today announced the launch of the F&P Nova Micro™ nasal pillows mask in New Zealand for the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) has initiated a voluntary limited recall of batches of Airvo 2 and myAirvo 2 devices manufactured before 14 August 2017.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has updated its revenue and earnings guidance for the financial year ending 31 March 2024.

Read more

Fisher & Paykel Healthcare Board Chair Scott St John has announced his intention to retire from the Board with effect from the close of the company’s annual shareholders’ meeting in August this year.

Read more

Fisher & Paykel Healthcare launches new selection and sizing tools in the F&P myMask™ App

Read more

Paul Shearer, the company’s Senior Vice President - Sales & Marketing, plans to retire from full-time duties on 31 March 2024.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan operating in respect of the dividend payable on Monday 18 December 2023 has been set.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the first half of the 2024 financial year.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Wednesday, 29 November 2023 its financial results for the six months ended 30 September 2023.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced the launch of the F&P Solo™ mask in New Zealand and Australia for the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has selected Charlotte Walshe to participate in the Future Directors programme, with effect from 1 January 2024.

Read more

Fisher & Paykel Healthcare celebrated the opening of the Sánchez Building, its third manufacturing facility in Mexico with an event at its Tijuana facility.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed.

Read more

Fisher & Paykel Healthcare Corporation Limited today provided earnings guidance for the first half of the 2024 financial year, which ends 30 September 2023.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided the attached Chair’s speech and CEO’s slide presentation for the 2023 Annual Shareholders’ Meeting.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided the attached Chair’s speech and CEO’s slide presentation for the 2023 Annual Shareholders’ Meeting.

Read more

Fisher & Paykel Healthcare Director Donal O’Dwyer has announced his intention to retire as a director of the company with effect from 31 December 2023.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the full year ended 31 March 2023.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced it will hold an Investor Event on Thursday, 14 September and Friday, 15 September 2023 in Tijuana, Mexico and Irvine, California.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Friday, 26 May 2023 its financial results for the year ended 31 March 2023.

Read more

Fisher & Paykel Healthcare welcomes Overseas Investment Office approval of Karaka site purchase

Read more

Fisher & Paykel Healthcare Corporation Limited today provided revenue guidance for the financial year ending 31 March 2023.

Read more

Dividend reinvestment plan strike price and AUD FX rate for interim dividend

Read more

Fisher & Paykel Healthcare announces results for the first half of the 2023 financial year

Read more

Fisher & Paykel Healthcare reactivates dividend reinvestment plan

Read more

Fisher & Paykel Healthcare to announce half year results on 29 November 2022

Read more

Fisher & Paykel Healthcare Corporation Limited announced today it has entered into an agreement, conditional on OIO approval, to acquire a 105 hectare site in Karaka, Auckland for $275 million.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided the attached Chair’s speech, CEO’s speech and slide presentation for the 2022 Annual Shareholders’ Meeting.

Read more

Fisher & Paykel Healthcare Corporation Limited today provided revenue and net profit after tax guidance for the first half of the 2023 financial year ending 30 September 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited published a notice of meeting on 6 July 2022 in relation to its Annual Shareholders’ Meeting to be held on Wednesday, 24 August 2022 at 2:00pm NZST.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided a copy of the Notice of Meeting for its 2022 Annual Shareholders’ Meeting.

Read more

Fisher & Paykel Healthcare Director Geraldine McBride has announced her intention to retire from the board with effect from the close of the company’s Annual Shareholders’ Meeting in August this year.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that Cather Simpson, PhD, has been appointed as a non-executive director of the company with effect from 1 June 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has selected Tracey Barron to participate in the Future Directors programme, with effect from 1 June 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the full year ended 31 March 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today it has launched two new products developed specifically for use in anesthesia applications.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today it has released the Airvo 3 high flow system.

Read more

Fisher & Paykel Healthcare has announced the United States launch of F&P Evora™ Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) announced today that it intends to release on Wednesday, 25 May 2022 its financial results for the year ended 31 March 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced it will hold an Investor Day on Thursday, 26 May 2022 following its financial results announcement on 25 May.

Read more

Fisher & Paykel Healthcare Corporation Limited today provided revenue guidance for the financial year ending 31 March 2022.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the first half of the 2022 financial year.

Read more

F&P Visairo is a new high-performance under-nose hospital mask with dynamic support technology.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced the launch of F&P Evora™ Full – its latest compact full-face mask for the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited has provided an update on the first four months of the 2022 financial year, which ended 31 July 2021

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the full year ended 31 March 2021.

Read more

Fisher & Paykel Healthcare wins Zenith Award from the American Association for Respiratory Care.

Read more

Fisher & Paykel Healthcare was honoured to win two categories in the Deloitte Top 200 Awards sponsored by Deloitte, the New Zealand Herald and New Zealand Media and Entertainment (NZME).

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the first half of the 2021 financial year, which ended 30 September 2020.

Read more

Auckland, New Zealand, 20 November 2020 – Fisher & Paykel Healthcare was honoured in two categories at the Designers Institute of New Zealand 2020 Best Design Awards.

Read more

Fisher & Paykel Healthcare was selected as a winner in the Success & Resilience Awards sponsored by the American Chamber of Commerce in New Zealand and DHL Express.

Read more

Fisher & Paykel Healthcare was selected the winner in Auckland Transport’s Travelwise Choices Awards in the category Excellence in Travel Choices.

Read more

Fisher & Paykel Healthcare was selected as the winner for the 2020 Jarden – Market Leaders Best Investor Relations at the INFINZ (Institute of Financial Professionals New Zealand) Awards.

Read more

Fisher & Paykel Healthcare celebrated the opening of the Daniell Building, its fourth research and development and manufacturing facility in New Zealand.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today its results for the full year ended 31 March 2020. Operating revenue was $1.26 billion, up 18% over last year.

Read more

Fisher & Paykel Healthcare Corporation Limited advises that the company’s results for the year ended 31 March 2020 will be released on Monday, 29 June 2020, instead of Thursday, 28 May 2020.

Read more

Following the announcement today by New Zealand’s Prime Minister that the COVID-19 alert status will be raised to Level 4 in 48 hours time, Fisher & Paykel Healthcare Corporation Limited advises...

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has further updated its revenue and earnings guidance for the financial year ended 31 March 2020.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has updated its revenue and earnings guidance for the financial year ended 31 March 2020.

Read more

Fisher & Paykel Healthcare Board Chairman Tony Carter has announced his intention to retire with effect from the close of the company’s annual shareholders’ meeting in August next year.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its financial results for the half year ended 30 September 2019.

Read more

Fisher & Paykel Healthcare celebrated its fiftieth anniversary by hosting a ‘World Fair’ event for 2,500 employees at their facility in East Tamaki.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that F&P Vitera™, its new mask for obstructive sleep apnea (OSA), is now available for sale in the United States.

Read more

Fisher & Paykel Healthcare was awarded a Value of Design Black Pin at the 21st annual Best Design Awards held by the Designers Institute of NZ (DINZ).

Read more

Fisher & Paykel Healthcare Corporation Limited announced that it has upgraded its earnings guidance for the financial year ending 31 March 2020 at its Annual Shareholders’ Meeting today.

Read more

Fisher & Paykel Healthcare today announced a record result for the 2019 financial year, with net profit after tax up 10% to NZ$209.2 million.

Read more

Fisher & Paykel Healthcare today announced a record result for the 2019 financial year, with net profit after tax up 10% to NZ$209.2 million.

Read more

FPH announced today that settlement of the global patent infringement litigation with ResMed will not have a material impact on its net profit after tax guidance for the 2019 financial year.

Read more

ResMed and Fisher & Paykel Healthcare today announced an agreement to settle all outstanding patent infringement disputes between the companies.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the half year ended 30 September 2018. Net profit after tax was NZ$97.4 million, up 20%.

Read more

Fisher & Paykel Healthcare advises that Neville Mitchell has been appointed as a non-executive director of the company.

Read more

Fisher & Paykel Healthcare announces new Chief Financial Officer

Read more

Fisher & Paykel Healthcare Corporation Limited announced that it has upgraded its earnings guidance for the financial year ending 31 March 2019 at its Annual Shareholders’ Meeting today.

Read more

Fisher & Paykel Healthcare Corporation Limited today reported record net profit after tax of NZ$190.2 million for the year ended 31 March 2018, an increase of 12% over the previous year.

Read more

New research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD patients using the myAirvo device.

Read more

New research shows significant benefits of Optiflow™ nasal high flow therapy for pediatric patients requiring respiratory support.

Read more

Fisher & Paykel Healthcare today announced its results for the half year ended 30 September 2017. Net profit after tax was NZ$81.3 million, up 4% from the prior comparable period.

Read more

Fisher & Paykel Healthcare Corporation Limited has today announced a UK Court ruling that a patent asserted against it by ResMed is invalid.

Read more

Fisher & Paykel Healthcare Corporation Limited announces that it has updated its earnings guidance for the financial year ending 31 March 2018.

Read more

Pip Greenwood has been appointed as a non-executive director of Fisher & Paykel Healthcare with effect from 1 June 2017.

Read more

Fisher & Paykel Healthcare Corporation Limited today reported record net profit after tax of NZ$169.2 million for the year ended 31 March 2017, an increase of 18% over the previous year.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the release of F&P SleepStyle™, a CPAP device used in the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the introduction of F&P Optiflow Junior 2.

Read more

Fisher & Paykel Healthcare has won a Red Dot Product Design Award for its F&P Brevida™ nasal pillows mask, used in the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited advises that a former employee appeared in the Auckland District Court today and pleaded guilty to charges laid by the Serious Fraud Office (SFO)...

Read more

Fisher & Paykel Healthcare’s F&P Brevida™ mask has won a prestigious Product Design award from independent German design organisation, iF International Forum Design GmbH.

Read more

Last night, former Fisher & Paykel Healthcare Managing Director and CEO Mike Daniell was presented with the New Zealand Shareholders’ Association (NZSA) Beacon Award.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced its results for the half year ended 30 September 2016. Net profit after tax was up 26% for the half at a record NZ$78.2 million.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) announced today that it has selected Rachael Newsome to participate in the Future Directors programme.

Read more

Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today welcomed new research on the benefits of its Optiflow™ nasal high flow therapy.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has updated its earnings guidance for the financial year ending 31 March 2017, and commenced a new building programme in New Zealand and Mexico.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the introduction of the F&P Nivairo™, a hospital mask for non-invasive ventilation therapy.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the introduction of an innovative new mask, the F&P Brevida™.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the introduction of an innovative new product, the F&P 950 Heated Humidification System.

Read more

Fisher & Paykel Healthcare Corporation Limited today reported record net profit after tax of NZ$143.4 million for the year ended 31 March 2016, an increase of 27% over the prior year.

Read more

Following the announcement in August 2015 that Michael Daniell would retire as Managing Director and Chief Executive Officer of Fisher & Paykel Healthcare, the company today advises that Lewis Gradon has now been appointed as Managing Director and Chief Executive Officer, effective 1 April, 2016.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it has selected Nicky Bell as its second participant in the Future Directors programme.

Read more

Fisher & Paykel Healthcare Chairman Tony Carter was presented with the 2015 Beacon Award by the New Zealand Shareholder’s Association last week.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced record net profit after tax of NZ$62.0 million for the half year ended 30 Sept 2015, an increase of 27% over the first half last year.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it has upgraded its earnings guidance for the financial year ending 31 March 2016.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced that Managing Director and Chief Executive Officer, Michael Daniell, has advised the company’s board that he intends to retire by the end of the current financial year. He will remain as a director on the Fisher & Paykel Healthcare board.

Read more

Fisher & Paykel Healthcare Corporation Limited today reported record net profit after tax of NZ$113.2 million for the full year, an increase of 17% over the prior year.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) today announced the introduction of a range of innovative new products for use with the AIRVO 2 system. These new products, used in delivering nasal high flow therapy, include the Optiflow™+ nasal cannula range, AirSpiral™ tube and an uninterruptible power supply (UPS) transport system for continuous therapy during transport within the hospital.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it intends to release on Friday, 29 May 2015 its financial results for the year ended 31 March 2015. The release will be issued shortly after 9:00am NZST, 7:00am AEST (5:00pm USEDT, Thursday, 28 May).

Read more

Fisher & Paykel Healthcare Corporation Limited has provided a copy of its Interim Report for the six months ended 30 September 2014.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced record net profit after tax of NZ$48.9 million for the half year, an increase of 10% over the first half last year.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it is supporting the Future Directors initiative, with the appointment of an aspiring director, Franceska Banga, as an observer of Fisher & Paykel Healthcare Board meetings.

Read more

Auckland, New Zealand, 20 August 2014 - Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today at its annual shareholders’ meeting that it has updated its earnings guidance for the financial year ending 31 March 2015.

Read more

Fisher & Paykel Healthcare Corporation Limited today announced record financial results for the financial year ended 31 March 2014.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Friday, 23 May 2014 its financial results for the year ended 31 March 2014. The release will be issued shortly after 9:00am NZST, 7:00am AEST (5:00pm USEDT, Thursday, 22 May).

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it had raised its earnings guidance and will expand its manufacturing facility in Tijuana, Mexico.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided a copy of its Interim Report for the six months ended 30 September 2013.

Read more

Fisher & Paykel Healthcare Corporation Limited today reported record net profit after tax of NZ$44.5 million for the six months ended 30 September 2013, an increase of 34% compared to the first half last year.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today the new F&P Simplus full face mask won both Gold and Purple Pin prize awards at the New Zealand BEST Awards (The Designers Institute)...

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced at its investor day in Sydney today the introduction of the F&P Pilairo™ Q nasal pillows mask for the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed.

Read more

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today at its annual shareholders’ meeting that it has raised its earnings guidance for the financial year ending 31...

Read more

Fisher & Paykel Healthcare was awarded Exporter of the Year in the over NZ$5 million category at the 14th annual American Chamber of Commerce DHL Express Success & Innovation Awards.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided a copy of its Notice of Annual Shareholders’ Meeting 2013 which will be held at the Paykel Building, 15 Maurice Paykel Place, East Tamaki...

Read more

Fisher & Paykel Healthcare Corporation Limited advises that Geraldine McBride has been appointed as an additional non-executive director of the company effective 1 August 2013.

Read more

Fisher & Paykel Healthcare Corporation Limited has provided a copy of its Annual Report for the year ended 31 March 2013, Annual Review for the year ended 31 March 2013 and a copy of its section 209 notice.

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Thursday, 23 May its financial results for the year ended 31 March 2013...

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has introduced F&P ICON+, the next generation of its flow generator range for use in the treatment of obstructive sleep apnea...

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it had raised its earnings guidance and has introduced a new full face mask range for use in the treatment of obstructive sleep apnea (OSA).

Read more

Fisher & Paykel Healthcare Corporation Limited today reported net profit after tax of NZ$33.3 million for the six months ended 30 September 2012, an increase of 18% compared to the first half last...

Read more

Fisher & Paykel Healthcare Corporation Limited advise that Donal O’Dwyer has been appointed as an additional non-executive director of the company effective 1 December 2012.

Read more

Slides from the Fisher & Paykel Healthcare 2012 Annual Shareholders' Meeting.

Read more

This is my first Annual Meeting as Chairman and I would first like to take the opportunity to acknowledge Gary Paykel and to reflect on the company’s progress over the past decade...

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it has expanded its nasal mask offering with the introduction of the F&P Eson™ nasal mask for use in the treatment of obstructive...

Read more

Fisher & Paykel Healthcare Corporation Limited today announced that expanding clinical applications for its medical devices and new products contributed to record operating revenue of NZ$516.7...

Read more

Fisher & Paykel Healthcare Corporation Limited announced today that it intends to release on Friday, 25 May its financial results for the year ended 31 March 2012. The release will be issued shortly after 9:00am NZST, 7:00am AEST (5:00pm USEDT, Thursday, 24 May).

Read more